Hyftor Evrópusambandið - íslenska - EMA (European Medicines Agency)

hyftor

plusultra pharma gmbh - sirolimus - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.

Mirtazapin Bluefish Munndreifitafla 15 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

mirtazapin bluefish munndreifitafla 15 mg

bluefish pharmaceuticals ab - mirtazapinum inn - munndreifitafla - 15 mg

Mirtazapin Bluefish Munndreifitafla 30 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

mirtazapin bluefish munndreifitafla 30 mg

bluefish pharmaceuticals ab - mirtazapinum inn - munndreifitafla - 30 mg